Farther Finance Advisors’s Prime Medicine PRME Stock Holding History

Farther Finance Advisors’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203	Sell	55 -99	-64%	-$329	﹤0.01%	5716
2026 Q1	$522	Buy	154 +83	+117%	+$316	﹤0.01%	5259
2025 Q4	$246	Hold	71	–	–	﹤0.01%	5179
2025 Q3	$393	Buy	71 +45	+173%	+$183	﹤0.01%	4597
2025 Q2	$64	Sell	26 -10,737	-100%	-$16.6K	﹤0.01%	4356
2025 Q1	$19.2K	Buy	10,763 +10,737	+41,296%	+$27.4K	﹤0.01%	2406
2024 Q4	$76	Hold	26	–	–	﹤0.01%	3829
2024 Q3	$101	Hold	26	–	–	﹤0.01%	3775
2024 Q2	$142	Hold	26	–	–	﹤0.01%	3549
2024 Q1	$176	Buy	+26	New	+$197	﹤0.01%	3296

Other funds holding PRME

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

APG

Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return

SWM

Shelton Wealth Management Fort Worth, Texas $255M AUM 34.47% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

OCWP

Owl Creek Wealth Partners Denver, Colorado $342M AUM

Farther Finance Advisors's PRME Position: Q2 2026 in Review

Farther Finance Advisors reduced its Prime Medicine (PRME) stake by 64% in Q2 2026, selling an estimated $329 and leaving 55 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #5716.

Farther Finance Advisors first reported a position in PRME in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.2K in Q1 2025. 18 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

Farther Finance Advisors held 55 shares of Prime Medicine worth $203 as of Q2 2026.
Farther Finance Advisors sold 99 Prime Medicine shares in Q2 2026, an estimated $329.
Prime Medicine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5716 holding.
Farther Finance Advisors first reported a position in Prime Medicine in Q1 2024 and has held it in 10 quarters since.
Farther Finance Advisors's Prime Medicine position peaked at $19.2K in Q1 2025.
18 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.